Patient Leaflet Updated 19-Jul-2024 | AstraZeneca UK Limited
Arimidex 1mg Film-Coated Tablet
Arimidex® 1 mg film-coated tablets
anastrozole
1. What Arimidex is and what it is used for
2. What you need to know before you take Arimidex
3. How to take Arimidex
4. Possible side effects
5. How to store Arimidex
6. Contents of the pack and other information
Arimidex contains a substance called anastrozole. This belongs to a group of medicines called ‘aromatase inhibitors’. Arimidex is used to treat breast cancer in women who have gone through the menopause and as a preventative treatment in postmenopausal women at moderate or high risk of breast cancer.
Arimidex works by cutting down the amount of the hormone called oestrogen that your body makes. It does this by blocking a natural substance (an enzyme) in your body called ‘aromatase’.
Do not take Arimidex if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking Arimidex.
Talk to your doctor, or pharmacist or nurse before taking Arimidex
If you are not sure if any of the above applies to you, talk to your doctor or pharmacist before taking Arimidex.
If you go into the hospital, let the medical staff know you are taking Arimidex.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines that you buy without a prescription and herbal medicines. This is because Arimidex can affect the way some medicines work and some medicines can have an effect on Arimidex.
Do not take Arimidex if you are already taking any of the following medicines:
If this applies to you, ask your doctor or pharmacist for advice.
Tell your doctor or pharmacist if you are taking the following:
Do not take Arimidex if you are pregnant or breast-feeding. Stop Arimidex if you become pregnant and talk to your doctor.
If you are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Arimidex is not likely to affect your ability to drive or use any tools or machines. However, some people may occasionally feel weak or sleepy while taking Arimidex. If this happens to you, ask your doctor or pharmacist for advice.
Arimidex contains lactose which is a type of sugar. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
This medicine contains less than 1 mmol sodium (23 mg) per tablet, that is to say essentially ‘sodium free’.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Keep taking Arimidex for as long as your doctor or pharmacist tells you to. It is a long-term treatment and you may need to take it for several years. Check with your doctor or pharmacist if you are not sure.
Arimidex should not be given to children and adolescents.
If you take more Arimidex than you should, talk to a doctor straight away.
If you forget to take a dose, just take your next dose as normal.
Do not take a double dose (two doses at the same time) to make up for a forgotten dose.
Do not stop taking your tablets unless your doctor tells you to.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If any of the side effects get worse, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist.
Common (may affect up to 1 in 10 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Very common side effects (affect more than 1 in 10 people)
Common side effects (affect 1 to 10 people in 100)
Uncommon side effects (affect 1 to 10 people in 1,000)
Rare side effects (affect 1 to 10 people in 10,000)
Arimidex lowers the amount of the hormone called estrogen that is in your body. This may lower the mineral content of your bones. Your bones may be less strong and may be more likely to fracture. Your doctor will manage these risks according to treatment guidelines for managing bone health in women who have gone through the menopause. You should talk to your doctor about the risks and treatment options.
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects via the Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Do not store above 30°C.
Keep this medicine out of the sight and reach of children. Keep your tablets in a safe place where children cannot see or reach them. Your tablets could harm them.
Do not use this medicine after the expiry date which is stated on the carton and blister strip after ‘EXP’. The expiry date refers to the last day of that month.
Keep your tablets in the container they came in.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
White, round, biconvex film-coated tablets of about 6.1 mm marked ‘A’ on one side and ‘Adx1’ on the other side.
Arimidex comes in blister packs of 28 tablets.
The Marketing Authorisation for Arimidex 1 mg film-coated tablets marketed in the UK is held by
This medicinal product is authorised in the Member States of the EEA under the following names:
Member State Name
Austria, Belgium, Bulgaria, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Spain, Sweden, UK Arimidex
Slovenia Arimidex 1mg filmsko obložene tablete
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge:
0800 198 5000 (UK only)
Please be ready to give the following information:
Product name Arimidex 1 mg Tablets
Reference number 17901/0002
This is a service provided by the Royal National Institute of Blind People.
This leaflet was last revised in March 2024.
© AstraZeneca 2024
Arimidex is a trade mark of the AstraZeneca group of companies.
ONC 24 0006
2 Pancras Square, 8th Floor, London, N1C 4AG, UK
+44 (0)1582 838 000
www.myazmed.co.uk
+44 (0)1582 836 000
0800 783 0033
https://medicalinformation.astrazeneca.co.uk/